Insulet Long Term Debt 2010-2024 | PODD

Insulet long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
  • Insulet long term debt for the quarter ending September 30, 2024 was $1.356B, a 1.04% decline year-over-year.
  • Insulet long term debt for 2023 was $1.366B, a 0.57% decline from 2022.
  • Insulet long term debt for 2022 was $1.374B, a 10.05% increase from 2021.
  • Insulet long term debt for 2021 was $1.249B, a 19.65% increase from 2020.
Insulet Annual Long Term Debt
(Millions of US $)
2023 $1,366
2022 $1,374
2021 $1,249
2020 $1,044
2019 $888
2018 $592
2017 $566
2016 $333
2015 $172
2014 $166
2013 $119
2012 $104
2011 $109
2010 $69
2009 $89
Insulet Quarterly Long Term Debt
(Millions of US $)
2024-09-30 $1,356
2024-06-30 $1,360
2024-03-31 $1,363
2023-12-31 $1,366
2023-09-30 $1,371
2023-06-30 $1,369
2023-03-31 $1,369
2022-12-31 $1,374
2022-09-30 $1,380
2022-06-30 $1,385
2022-03-31 $1,391
2021-12-31 $1,249
2021-09-30 $1,257
2021-06-30 $1,235
2021-03-31 $1,052
2020-12-31 $1,044
2020-09-30 $922
2020-06-30 $910
2020-03-31 $899
2019-12-31 $888
2019-09-30 $986
2019-06-30 $607
2019-03-31 $600
2018-12-31 $592
2018-09-30 $584
2018-06-30 $577
2018-03-31 $570
2017-12-31 $566
2017-09-30 $345
2017-06-30 $341
2017-03-31 $337
2016-12-31 $333
2016-09-30 $329
2016-06-30 $176
2016-03-31 $174
2015-12-31 $172
2015-09-30 $175
2015-06-30 $175
2015-03-31 $175
2014-12-31 $166
2014-09-30 $171
2014-06-30 $175
2014-03-31 $121
2013-12-31 $119
2013-09-30 $117
2013-06-30 $112
2013-03-31 $106
2012-12-31 $104
2012-09-30 $102
2012-06-30 $99
2012-03-31 $111
2011-12-31 $109
2011-09-30 $106
2011-06-30 $104
2011-03-31 $71
2010-12-31 $69
2010-09-30 $94
2010-06-30 $92
2010-03-31 $98
2009-12-31 $89
2009-09-30 $96
2009-06-30 $83
2009-03-31 $81
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $18.698B $1.697B
Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $198.127B 25.27
Stryker (SYK) United States $138.991B 31.32
Boston Scientific (BSX) United States $131.097B 37.69
EssilorLuxottica (ESLOY) France $109.895B 0.00
Medtronic (MDT) Ireland $103.904B 15.43
Haleon (HLN) United Kingdom $43.864B 28.50
Lonza Group Ag (LZAGY) Switzerland $42.859B 0.00
GE HealthCare Technologies (GEHC) United States $36.052B 18.70
ResMed (RMD) United States $34.830B 28.62
Terumo (TRUMY) Japan $28.875B 0.00
Koninklijke Philips (PHG) Netherlands $23.602B 18.07
Zimmer Biomet Holdings (ZBH) United States $21.325B 13.58
Baxter (BAX) United States $15.062B 9.80
Smith & Nephew SNATS (SNN) United Kingdom $10.781B 0.00
BellRing Brands (BRBR) United States $9.800B 39.43
Bio-Rad Laboratories (BIO) United States $9.168B 31.16
Demant (WILYY) Denmark $7.926B 0.00
Lantheus Holdings (LNTH) United States $6.208B 14.42
Prestige Consumer Healthcare (PBH) United States $3.889B 19.34
ICU Medical (ICUI) United States $3.840B 36.56
Haemonetics (HAE) United States $3.789B 18.49
Perrigo (PRGO) Ireland $3.513B 10.34
Envista Holdings (NVST) United States $3.218B 23.97
QuidelOrtho (QDEL) United States $3.016B 19.41
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.864B 18.36
Neogen (NEOG) United States $2.609B 30.10
LeMaitre Vascular (LMAT) United States $2.071B 50.34
Green Thumb Industries (GTBIF) United States $1.678B 29.37
AtriCure (ATRC) United States $1.498B 0.00
InMode (INMD) Israel $1.434B 8.63
AdaptHealth (AHCO) United States $1.383B 9.88
Maravai LifeSciences Holdings (MRVI) United States $1.356B 0.00
BioLife Solutions (BLFS) United States $1.271B 0.00
Curaleaf Holdings (CURLF) Canada $0.968B 0.00
Owens & Minor (OMI) United States $0.965B 7.54
CeriBell (CBLL) United States $0.964B 0.00
Phibro Animal Health (PAHC) United States $0.879B 15.49
Evolus (EOLS) United States $0.690B 0.00
Omeros (OMER) United States $0.597B 0.00
Capricor Therapeutics (CAPR) United States $0.594B 0.00
VAREX IMAGING (VREX) United States $0.584B 25.75
Surmodics (SRDX) United States $0.568B 0.00
Verano Holdings (VRNOF) United States $0.452B 0.00
Cresco Labs (CRLBF) United States $0.439B 0.00
Quanterix (QTRX) United States $0.403B 0.00
ZimVie (ZIMV) United States $0.375B 31.63
Biote (BTMD) United States $0.331B 7.26
Valneva SE (VALN) France $0.324B 0.00
Viemed Healthcare (VMD) United States $0.311B 29.56
Canopy Growth (CGC) Canada $0.308B 0.00
Sanara MedTech (SMTI) United States $0.294B 0.00
Cerus (CERS) United States $0.293B 0.00
OraSure Technologies (OSUR) United States $0.272B 18.20
Zynex (ZYXI) United States $0.263B 55.00
High Tide (HITI) Canada $0.242B 100.33
Aurora Cannabis (ACB) Canada $0.234B 0.00
Utah Medical Products (UTMD) United States $0.207B 14.29
Sanuwave Health (SNWV) United States $0.201B 2.82
MacroGenics (MGNX) United States $0.200B 0.00
Organigram Holdings (OGI) Canada $0.197B 0.00
TerrAscend (TSNDF) Canada $0.190B 0.00
Brainsway (BWAY) Israel $0.174B 92.40
FitLife Brands (FTLF) United States $0.145B 18.17
Jin Medical (ZJYL) China $0.133B 0.00
TriSalus Life Sciences (TLSI) United States $0.124B 0.00
Quipt Home Medical (QIPT) United States $0.107B 0.00
Fonar (FONR) United States $0.096B 10.81
Oramed Pharmaceuticals (ORMP) United States $0.096B 0.00
Veru (VERU) United States $0.095B 0.00
Exagen (XGN) United States $0.091B 0.00
InterCure (INCR) Israel $0.068B 0.00
Rockwell Medical (RMTI) United States $0.067B 34.67
Apyx Medical (APYX) United States $0.059B 0.00
Jushi Holdings (JUSHF) United States $0.056B 0.00
Ayr Wellness (AYRWF) United States $0.051B 0.00
Cytosorbents (CTSO) United States $0.050B 0.00
Modular Medical (MODD) United States $0.048B 0.00
Safety Shot (SHOT) United States $0.044B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Allurion Technologies (ALUR) United States $0.023B 0.00
Nephros (NEPH) United States $0.016B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Innovative Eyewear (LUCY) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Trinity Biotech (TRIB) Ireland $0.006B 0.00
Agape ATP (ATPC) $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Sharps Technology (STSS) United States $0.003B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 12.74
SNDL (SNDL) Canada $0.000B 0.00